These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 21682595)
1. XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population. Warchoł T; Mostowska A; Lianeri M; Lącki JK; Jagodziński PP DNA Cell Biol; 2012 Jan; 31(1):50-6. PubMed ID: 21682595 [TBL] [Abstract][Full Text] [Related]
2. XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of systemic lupus erythematosus in an Iranian population: a pilot study. Salimi S; Mohammadoo-Khorasani M; Tabatabai E; Sandoughi M; Zakeri Z; Naghavi A Biomed Res Int; 2014; 2014():492956. PubMed ID: 24971336 [TBL] [Abstract][Full Text] [Related]
3. DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease. Trabulus S; Guven GS; Altiparmak MR; Batar B; Tun O; Yalin AS; Tunckale A; Guven M Mol Biol Rep; 2012 Jun; 39(6):6995-7001. PubMed ID: 22302399 [TBL] [Abstract][Full Text] [Related]
4. Involvement of the XRCC1 Arg399Gln gene polymorphism in the development of cervical carcinoma. Roszak A; Lianeri M; Jagodzinski PP Int J Biol Markers; 2011; 26(4):216-20. PubMed ID: 21928248 [TBL] [Abstract][Full Text] [Related]
5. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis. Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703 [TBL] [Abstract][Full Text] [Related]
6. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls. Huang Y; Xie D; Tang N; Wang J; Zeng X; Zhao P; He L Tumour Biol; 2014 Jan; 35(1):799-808. PubMed ID: 23990457 [TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the DNA repair gene XRCC1 and associations with systemic lupus erythematosus risk in the Taiwanese Han Chinese population. Lin YJ; Wan L; Huang CM; Chen SY; Huang YC; Lai CH; Lin WY; Liu HP; Wu YS; Chen CM; Tsai YH; Tsai CH; Sheu JJ; Tsai FJ Lupus; 2009 Dec; 18(14):1246-51. PubMed ID: 19880550 [TBL] [Abstract][Full Text] [Related]
8. DNA repair genes XPD and XRCC1 polymorphisms and risk of end-stage renal disease in Egyptian population. Radwan WM; Elbarbary HS; Alsheikh NM Ren Fail; 2015 Feb; 37(1):122-8. PubMed ID: 25310768 [TBL] [Abstract][Full Text] [Related]
9. Association of X-ray repair cross complementing group 1 Arg399Gln polymorphisms with the risk of squamous cell carcinoma of the head and neck: evidence from an updated meta-analysis. Wang Y; Chu X; Meng X; Zou F PLoS One; 2013; 8(10):e77898. PubMed ID: 24205020 [TBL] [Abstract][Full Text] [Related]
10. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis. Qi Y; Cui L; Song Y; Li N Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232 [TBL] [Abstract][Full Text] [Related]
11. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population. Yang HY; Yang SY; Shao FY; Wang HY; Wang YD Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477 [TBL] [Abstract][Full Text] [Related]
12. An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk. Wang YD; Zhai WL; Wang HY; Xia XQ Asian Pac J Cancer Prev; 2014; 15(11):4443-8. PubMed ID: 24969866 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of DNA repair gene XRCC1 polymorphism in prediction and prognosis of hepatocellular carcinoma risk. Li QW; Lu CR; Ye M; Xiao WH; Liang J Asian Pac J Cancer Prev; 2012; 13(1):191-4. PubMed ID: 22502666 [TBL] [Abstract][Full Text] [Related]
14. XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis. Geng J; Zhang YW; Huang GC; Chen LB World J Gastroenterol; 2008 Nov; 14(43):6733-7. PubMed ID: 19034980 [TBL] [Abstract][Full Text] [Related]
15. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk. Dong LM; Zhang XY; Teng H; Li MS; Wang P Genet Mol Res; 2014 Nov; 13(4):9976-85. PubMed ID: 25501209 [TBL] [Abstract][Full Text] [Related]
16. Association between Arg399Gln polymorphism of X-ray repair cross-complementing 1 (XRCC1) gene and sporadic endometrial cancer in the Polish population. Samulak D; Romanowicz-Makowska H; Smolarz B; Kulig A; Sporny S Eur J Gynaecol Oncol; 2011; 32(5):491-5. PubMed ID: 22053659 [TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case-control study. Saadat M; Kohan L; Omidvari S Breast Cancer Res Treat; 2008 Oct; 111(3):549-53. PubMed ID: 17987379 [TBL] [Abstract][Full Text] [Related]
18. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects. Xia S; Wu S; Wang M Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875 [TBL] [Abstract][Full Text] [Related]
19. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease. Yang SF; Xu YJ; Xie JG; Zhang ZX Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423 [TBL] [Abstract][Full Text] [Related]
20. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Saadat M; Ansari-Lari M Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]